Home › All Companies › SER › Current Report

Serina Therapeutics, Inc. (SER) — Current Report

AI-Powered SEC Filing Analysis

← All SER filings
Latest Current Report Filed: 2026-03-25

Key Insights

  • Serina Therapeutics reported its financial results for the year ended December 31, 2025, which provide investors with an update on the company's performance and financial condition.
  • The company did not disclose any material agreements, leadership changes, or earnings surprises that would be considered significant events for investors.
  • Without any major news or updates in this 8-K filing, the significance of this information is relatively routine for investors.
Sentiment: Neutral Significance: 2/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-25. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Serina Therapeutics, Inc.

Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.